1Calhoun DA,Jones D, Textor S, et al. Resistant Hypertension: Diagnosis, Evaluation, and Treatment: A Scientific Statement From the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension, 2008, 51: 1403-1419.
2Mosso L, Carvajal C, Gonzalez A, et al. Primary aldosteronism and hypertensive disease. Hypertension, 2003, 42: 161-165.
4Gomez-Sanchez CE, Gomez-Sanchez EP, Yamakita N. Endocrine cause of hypertension. Semin Nephol, 1995, 15 : 106-115.
5Radomski MW, Palmer RM, Moncada S. Glueocorticoids inhibit the expression of an inducible but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci U S A, 1990, 87 : 10043-10047.
6Wallerath T, Witte K, Schafer SC, et al. Down regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoid-mediated hypertension. Proc Natl Acad Sci U S A, 1999, 96: 13357-13362.
7Simmons WW, Ungureanu-Longrois D, Smith GK, et al. Glucocorticoids regulate inducible nitric oxide synthase by inhibiting tetrahydrobiopterin synthesis and L-arginine transport. J Biol Chem, 1996, 271: 23928-23937.
8Kell JJ, Martin A, Whitworth JA. Role of erythropoietin in cortisol-induced hypertension. J Hum Hypertens, 2000, 14 : 195-198.
9Kem DC ,Weinberger MH, Gomez-Sanchez C, et al. The role of ACTH in the episodic release of aldosterone in patients with idiopathic adrenal hyperplasia, hypertension, and hyperaldosteronisrn. J Lab Clin Med, 1976, 88 : 261-270.
